Immunotherapy Program News Today

Guidelines in distancing guidelines. We have Fox Team Coverage on the latest response at home and abroad. We begin with Mark Meredith reporting live from the white house. Mark. Reporter good eave nick, jon. The president s advisor are meeting for the Coronavirus Task force, this was a briefing we expected to happen via conference call, now it is happening in the white house situation room. Weve seen a few of the advisors starting to show up. The president as you mentioned tweeted he may or may n...

Jason Luke, MD, FACP, discusses key takeaways from the KEYNOTE-716 and KEYNOTE-942 trials and other key updates from across the melanoma landscape presented at the 2023 ASCO Annual Meeting.

Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of hepatocellular carcinoma. This is a proof of concept that lays the foundations for the application of this treatment in patients with the most common liver cancer.

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma

Jason Luke, MD, FACP, discusses the final analysis of distant metastasis–free survival in the phase 3 KEYNOTE-716 trial of pembrolizumab vs placebo as adjuvant therapy in patients with stage IIB or IIC melanoma.

Proof of mechanism and safety has been established for the first-in-class bisialidase and Fc fusion protein E-602 in advanced solid tumors, supporting its continued investigation and viability of harnessing glycan-mediated immune regulation as a novel therapeutic approach in this population.

Inhaling menthol could stave off the devastating memory loss and mental decline associated with the most common form of dementia, Spanish researchers have reported.

Internationally recognised cancer expert, Professor Brendan Jenkins, has received the International Cytokine and Interferon Society (ICIS) 2023 Distinguished Service Award. He will be presented with the award at the annual ICIS conference in Athens,

Researchers from Cima University of Navarra (Spain) have shown in animal models of Alzheimer's disease that inhaling menthol improves cognitive ability.

Jason J. Luke, MD, FACP, discusses initial results from the phase 1 GLIMMER-01 trial of E-602 in advanced solid tumors.